Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 4164.00 | 4133.00 | 1.0075 | 1.0091 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 3988.00 | 4133.00 | 0.9649 | 0.9573 |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 3889.00 | 4133.00 | 0.9410 | 0.9278 |
| BT-20 | Erlotinib | 1 | uM | 7 | 2500.00 | 1312.79 | 3372.00 | 4133.00 | 0.8159 | 0.7685 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 2500.00 | 1312.79 | 2450.00 | 4133.00 | 0.5928 | 0.4581 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4075.00 | 4133.00 | 0.9860 | 0.9830 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 3920.00 | 4133.00 | 0.9485 | 0.9371 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 1389.00 | 4133.00 | 0.3361 | 0.0347 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4198.00 | 4133.00 | 1.0157 | 1.0190 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4.00 | 4133.00 | 0.0010 | -0.9699 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 0.00 | 4133.00 | 0.0000 | -1.0000 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4081.00 | 4133.00 | 0.9874 | 0.9848 | |
| BT-20 | 17-AAG | 10 | uM | 7 | 2500.00 | 1312.79 | 1294.00 | 4133.00 | 0.3131 | -0.0087 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 2500.00 | 1312.79 | 4118.00 | 4133.00 | 0.9964 | 0.9956 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4300.00 | 4133.00 | 1.0404 | 1.0485 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4184.00 | 4133.00 | 1.0123 | 1.0149 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4173.00 | 4133.00 | 1.0097 | 1.0117 | |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3345.00 | 4133.00 | 0.8093 | 0.7600 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 2500.00 | 1312.79 | 4587.00 | 4133.00 | 1.1098 | 1.1300 |
| BT-20 | Linsitinib | 1 | uM | 7 | 2500.00 | 1312.79 | 4014.00 | 4133.00 | 0.9712 | 0.9650 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3326.00 | 4133.00 | 0.8047 | 0.7539 |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4411.00 | 4133.00 | 1.0673 | 1.0803 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 1298.00 | 4133.00 | 0.3141 | -0.0068 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 2500.00 | 1312.79 | 2854.00 | 4133.00 | 0.6905 | 0.5990 |
| BT-20 | Lapatinib | 1 | uM | 7 | 2500.00 | 1312.79 | 3694.00 | 4133.00 | 0.8938 | 0.8688 |